However, sub-cluster G7 was negatively correlated with CD4+ T cell activation in aCD20-treated MS patients, again suggesting disease- or treatment-mediated differences in granulocytes functions, which are in line with previously published study on neutrophil alteration in NMOSD patients7–10. The gene discussed is CD4; the disease is myeloid sarcoma.